drugset / Trial / NCT00004881

Vaccine Therapy in Treating Patients With Advanced Cancer

NCT00004881

Treatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have advanced cancer.

Timeline

Start
2000-04
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject MVA-MUC1-IL2 Vaccine Intramuscular